Delivery Order SPE2DB20D2002-SPE2DB21FL53P
Award Date 8/20/21
Potential Completion Date 8/23/21
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,096.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,317,911 units of Clindamycin HCL 300 mg capsules in 100-count bottles. The contract has a period of performance through February 20, 2025 and was awarded on February 19, 2025. This delivery order appears to be part of a larger Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,554,462,418 units of Clindamycin HCL 300 mg capsules in 100 count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 18, 2021. The contract has a ceiling value of $1,239.28 and is a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award, valued at $1,154.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 900 mg/50 ml-D5W 50 ml, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This federal contract award is a delivery order valued at $15,053.24 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The award is for the provision of 4,558,161,196 units of the medication Clindamycin HCL 300 mg capsules. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,148.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,814,685 units of Clindamycin HCL 150 mg capsules. This contract has an ultimate completion date of September 17, 2024 and does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA and other federal agencies to provide a wide range of...
- This federal contract award for $7,565.69 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the supply of 4,558,127,939 units of Clindamycin HCL 300 mg capsules in 100-count bottles. This contract does not have a set-aside designation, indicating...
- This federal contract award, with a ceiling value of $1,161.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Clindamycin PH 1% Solution, a pharmaceutical product, and has an ultimate completion date of January 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support...
- This federal contract award, valued at $1,246.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLINDAMYCIN 600 MG/50 ML-D5W 50ML, a medical product, with a completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Clindamycin 150mg pharmaceutical products, with a ceiling value of $6,626.06 and an ultimate completion date of August 7, 2024. The contract is a Delivery Order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Clindamycin HCl 300 mg capsules (100-count units) with a ceiling value of $1,200.84. This firm fixed-price delivery order, with an ultimate completion date of July 11, 2025, represents a non-set-aside competitive award performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The award is a child contract executed under AmerisourceBergen's larger...